Last updated on September 2018

A Study To Establish the Prevalence of Mutations in Patients With CML and Ph+ ALL Currently Being Treated With TKI Therapy in the UK


Brief description of study

A multicenter, prospective cohort study of the mutation status of patients with chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who are being treated with first or subsequent tyrosine kinase inhibitor (TKI) therapy in the UK.

Clinical Study Identifier: NCT03647215

Contact Investigators or Research Sites near you

Start Over

Incyte Corporation Call Center (ex-US)

Royal Cornwall Hospital
Truro, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Royal Devon & Exeter Hospital
Exeter, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Derriford Hospital
Plymouth, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Queen's Hospital
Romford, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Aberdeen Royal Infirmary
Aberdeen, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Queen Alexandra Hospital
Portsmouth, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Medway Maritime Hospital
Gillingham, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Blackpool Victoria Hospital
Blackpool, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Royal Oldham Hospital
Manchester, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Queens Medical Centre
Nottingham, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Ipswich Hospital
Ipswich, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Heart of England NHS Foundation Trust
Birmingham, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Russells Hall Hospital
Dudley, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

St Bartholomew's Hospital
London, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Bradford Royal Infirmary
Bradford, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

St James's University Hospital
Leeds, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Monklands Hospital
Airdrie, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

University Hospital Wales
Cardiff, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Croydon University Hospital, Croydon Health Services NHS Trust
Croydon, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Western General Hospital
Edinburgh, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Beatson West of Scotland Cancer Centre
Glasgow, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

King's College Hospital
London, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

The James Cook University Hospital, South Tees Hospitals NHS Foundation Trust
Middlesbrough, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS FT
Sheffield, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Royal Stoke University Hospital, Cancer Centre, University Hospitals of North Midlands NHS Trust
Stoke-on-Trent, United Kingdom
  Connect »

Incyte Corporation Call Center (ex-US)

Singleton Hospital
Swansea, United Kingdom
  Connect »